Latest News about AXSM
Recent news which mentions AXSM
Benzinga's Top Upgrades, Downgrades For January 8, 2021
January 08, 2021
From Benzinga
3 Biotech Stocks That Could Explode Higher in 2021
December 21, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For December 16, 2020
December 16, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
From Benzinga
Why These 4 Pharma Stocks Are Moving Today
December 01, 2020
From Benzinga
5 Under-the-Radar Tickers That Will Stomp the Market in 2021
November 19, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For September 29, 2020
September 29, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut
September 29, 2020
From Benzinga
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
September 24, 2020
From Benzinga
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
September 23, 2020
From Benzinga
2 Biotech Stocks with Jaw-Dropping Growth Potential
September 13, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For September 10, 2020
September 10, 2020
From Benzinga
The Daily Biotech Pulse: CureVac Close To Coronavirus Vaccine Deal With EU, Entera Bio's Positive Readout, Patent Protection For Co-Diagnostics
August 20, 2020
From Benzinga
Tickers
AXSM
From Motley Fool
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
August 09, 2020
From Benzinga
These Stocks Would Have Doubled Your Money Last Year
July 25, 2020
From Motley Fool
Tickers
AXSM
From Motley Fool
From Motley Fool
81 Biggest Movers From Friday
June 29, 2020
From Benzinga
60 Stocks Moving In Friday's Mid-Day Session
June 26, 2020
From Benzinga
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
June 26, 2020
From Benzinga
Is Aurinia Pharmaceuticals Stock a Buy?
June 09, 2020
From Motley Fool
From Motley Fool
Is Axsome Therapeutics a Buy?
May 26, 2020
From Motley Fool
Better Buy: Biogen vs. Axsome Therapeutics
May 23, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.